Pulse Historical Income Statement
| PLSE Stock | USD 19.63 1.84 10.34% |
Historical analysis of Pulse Biosciences income statement accounts such as Total Operating Expenses of 36.2 M, Total Other Income Expense Net of 1.6 M, Income Tax Expense of 541 K or Tax Provision of 0.0 can show how well Pulse Biosciences performed in making a profits. Evaluating Pulse Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Pulse Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Pulse Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pulse Biosciences is a good buy for the upcoming year.
Pulse |
About Pulse Income Statement Analysis
Pulse Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Pulse Biosciences shareholders. The income statement also shows Pulse investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Pulse Biosciences Income Statement Chart
Add Fundamental
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Pulse Biosciences minus its cost of goods sold. It is profit before Pulse Biosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Pulse Biosciences. It is also known as Pulse Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from Pulse Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Pulse Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulse Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.At present, Pulse Biosciences' Cost Of Revenue is projected to increase significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 1.6 M, whereas Total Revenue is projected to grow to (9.8 K).
| 2022 | 2023 | 2024 | 2025 (projected) | Other Operating Expenses | 58.8M | 43.6M | 50.1M | 41.9M | Depreciation And Amortization | 1.4M | 1.2M | 1.4M | 1.1M |
Pulse Biosciences income statement Correlations
Click cells to compare fundamentals
Pulse Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pulse Biosciences income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Selling General Administrative | 22.9M | 19.1M | 14.0M | 15.8M | 18.1M | 14.7M | |
| Total Revenue | 114K | 1.4M | 700K | (9K) | (10.4K) | (9.8K) | |
| Operating Income | (50.0M) | (63.0M) | (58.1M) | (43.6M) | (39.2M) | (41.2M) | |
| Net Income From Continuing Ops | (49.9M) | (63.7M) | (58.5M) | (39.5M) | (35.5M) | (37.3M) | |
| Ebit | (50.0M) | (63.0M) | (58.1M) | (43.6M) | (39.2M) | (41.2M) | |
| Research Development | 26.4M | 28.6M | 20.8M | 27.8M | 32.0M | 18.1M | |
| Total Operating Expenses | 50.0M | 62.5M | 46.8M | 43.6M | 50.1M | 36.2M | |
| Income Before Tax | (49.9M) | (63.7M) | (58.5M) | (42.2M) | (38.0M) | (39.9M) | |
| Total Other Income Expense Net | 114K | (646K) | (448K) | 1.4M | 1.6M | 1.6M | |
| Net Income Applicable To Common Shares | (37.5M) | (47.0M) | (49.9M) | (63.7M) | (57.3M) | (54.4M) | |
| Net Income | (49.7M) | (63.2M) | (59.0M) | (42.2M) | (38.0M) | (39.9M) | |
| Income Tax Expense | (983K) | (114K) | (500K) | 448K | 515.2K | 541.0K | |
| Depreciation And Amortization | 1.1M | 1.1M | 1.4M | 1.2M | 1.4M | 1.1M | |
| Other Operating Expenses | 50.0M | 64.4M | 58.8M | 43.6M | 50.1M | 41.9M | |
| Ebitda | (48.9M) | (61.9M) | (56.7M) | (42.4M) | (38.1M) | (40.0M) | |
| Net Interest Income | 114K | (646K) | (448K) | 312K | 280.8K | 294.8K | |
| Reconciled Depreciation | 1.1M | 1.1M | 1.4M | 1.2M | 1.4M | 1.3M | |
| Selling And Marketing Expenses | 7.3M | 14.8M | 12.0M | 1.2M | 1.1M | 1.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| S | SentinelOne | |
| CRM | Salesforce | |
| MSFT | Microsoft |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulse Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.